Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial.
about
Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Glibenclamide and metfoRmin ve ...... y open label randomised trial.
@en
Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS
@nl
type
label
Glibenclamide and metfoRmin ve ...... y open label randomised trial.
@en
Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS
@nl
prefLabel
Glibenclamide and metfoRmin ve ...... y open label randomised trial.
@en
Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS
@nl
P2093
P2860
P50
P1476
Glibenclamide and metfoRmin ve ...... ty open label randomised trial
@en
P2093
Ben Stenson
Claire I Alexander
Corinne D B Love
Ed Juszczak
Fiona Mackenzie
Jennifer L Bell
Jessica Penneycard
Mark W J Strachan
Robert S Lindsay
Sonia Whyte
P2860
P2888
P356
10.1186/S12884-017-1505-3
P577
2017-09-22T00:00:00Z
P6179
1091898506